NCT06222164View on ClinicalTrials.gov

The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research

RecruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

March 30, 2024

Primary Completion Date

March 30, 2027

Study Completion Date

June 30, 2027

Conditions
Hematologic Diseases
Trial Locations (1)

92121

RECRUITING

LabPMM, San Diego

All Listed Sponsors
lead

Invivoscribe, Inc.

INDUSTRY